| Patricia Rose Imasa, | |
|
336 Sable, Rancho Santa Margarita, CA 92688-5575 | |
| (949) 573-8529 | |
| Not Available |
| Full Name | Patricia Rose Imasa |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 336 Sable, Rancho Santa Margarita, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679234751 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 85786 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Rose Imasa, 336 Sable, Rancho Santa Margarita, CA 92688-5575 Ph: (949) 573-8529 | Patricia Rose Imasa, 336 Sable, Rancho Santa Margarita, CA 92688-5575 Ph: (949) 573-8529 |
News Archive
Stanford University School of Medicine scientists have discovered a novel class of compounds that, in experiments in vitro, inhibit replication of the virus responsible for hepatitis C. If these compounds prove effective in infected humans as well, they may dramatically accelerate efforts to confront this virus's propensity to rapidly acquire drug resistance, while possibly skirting some of the troubling side effects common among therapies in current use and in late-stage development.
A new study, released as a preprint on the bioRxiv* server, describes the late-stage clinical trial efficacy of a new vaccine candidate based on a deoxyribonucleic acid (DNA) plasmid platform expressing the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Among different constructs of the vaccine plasmid, the RBD was found to produce the most potent and broad immune response.
Researchers from the Massachusetts General Hospital Division of Infectious Diseases are investigating the mechanism by which several important pathogenic species of bacteria deliver proteins into the cells of the organisms they are infecting.
Cell Therapeutics, Inc. (CTI) announced today that on December 24, 2009, CTI's Board of Directors (the "Board of Directors") approved and adopted a Shareholder Rights Plan (the "Rights Plan") in which one preferred stock purchase right will be distributed for each common share held as of the close of business on January 7, 2010. Initially, the rights are not exercisable, and are attached to and trade with, all of the shares of CTI's common stock outstanding as of, and issued subsequent to, the record date.
› Verified 6 days ago
Dina Liswi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30602 Santa Margarita Pkwy, T-0914, Rancho Santa Margarita, CA 92688 Phone: 949-459-0973 Fax: 949-459-0973 | |
George Anthony Jelaco, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Firethorn, Rancho Santa Margarita, CA 92688 Phone: 949-241-0413 | |
Long Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30491 Avenida De Las Flores, Rancho Santa Margarita, CA 92688 Phone: 949-207-5155 Fax: 949-207-5155 | |
Aaron Ann, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30491 Avenida De Las Flores, Rancho Santa Margarita, CA 92688 Phone: 949-207-5070 | |
Shahla Manafian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 31541 Santa Margarita Pkwy, Rancho Santa Margarita, CA 92688 Phone: 949-858-7737 Fax: 949-858-9057 | |
Cyrus Sadeghian, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Via Puma, Rancho Santa Margarita, CA 92688 Phone: 909-262-4556 | |
Dr. Marielle Reyesbaje, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30602 Santa Margarita Pkwy, T-0914, Rancho Santa Margarita, CA 92688 Phone: 949-459-0973 |